Mylan Pharm is investing in a new cancer treatment gene therapy. They have projected the cost of final clinical trials to be $95,000,000 (now) and will take 3 years to complete then they have to get FDA approval which will take to year 5. The regulatory department has given the following projections and you have to determine if it should proceed with an 6% MARR? 40% chance of failure - No Revenue 45% chance of approval by FDA, 5 years from now, Revenue $23,000,000/ year for years 5-15 after approval 15% chance wider approval by FDA, 5 years from now, Revenue $30,000,000/year for years 5-15 -$4,320.000 No $2,229,920 Yes -$2,229,920 No $3,521,000 Yes